ArticleJAMA network open2018

Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial Design.

Sarah R Helman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.